JPRN-C000000403已完成1 期
HLA2-3 antigen mismatched stem cell transplantation from related donor - HLA2-3 antigen mismatched stem cell transplantation from related donor
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 45years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Allergy for the agents used in conditioning or GVHD prophylaxis 2) Patients who are considered as inappropriate with other reasons
研究者
相似试验
招募中
不适用
HLA 2-3 antigen-mismatched stem cell transplantation for refracotry hematologic malignanciesJPRN-UMIN000011985Jikei University School of Medicine25
尚未招募
2 期
Allogeneic hematopoietic stem cell transplantation from a two HLA-haplotype-mismatched family donor for post-transplant relapse/rejection: A prospective phase II study with statistical validation for survival benefithematologic malignancies relapsing or with rejection after allogeneic hematopoietic stem cell transplantationJPRN-UMIN000043973Hyogo College of Medicine50
未知
2 期
Hematopietic stem cell transplantation from HLA 2-3 antigen-mismatched family donor using reduced intensity conditioningJPRN-UMIN000023784Hyogo College of Medicine100
已完成
不适用
HLA-haploidentical allogeneic stem cell transplantation for refractory hematopoietic diseasesAcute myeloid leukemia(AML) Acute lymphoblastic leukemia (ALL) Secondary acute myelogenous leukemia Chronic myeloid leukemia (CML) Myelodysplastic syndrome (MDS)JPRN-UMIN000002069Hematology, Osaka City University, Graduate School of Medicine17
已完成
2 期
HLA-haploidentical allogeneic stem cell transplantation for refractory hematopoietic malignancies (OCU13-3)Acute myeloid leukemia(AML) Acute lymphoblastic leukemia (ALL) Chronic myeloid leukemia (CML) Myelodysplastic syndrome (MDS)JPRN-UMIN000011293Osaka City University35